Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Centro Regional de Hemodonación, University of Murcia, IMIB-Arrixaca , Murcia , Spain.
Red CIBERER CB15/00055 , Murcia , Spain.
Platelets. 2019;30(7):803-808. doi: 10.1080/09537104.2018.1475635. Epub 2018 May 22.
Although a growing number of studies suggest that microRNAs (miRNAs) play a relevant role in platelet biology, their implications in bleeding diatheses are starting to be investigated. Indeed, several studies have shown that alterations in the intracellular levels of highly expressed platelet miRNAs provoke a thrombotic phenotype. On the other hand, primary immune thrombocytopenia (ITP), which is considered the hallmark of acquired bleeding disorders, has been recently associated with altered levels of miRNAs in peripheral blood mononuclear cells, plasma, and platelets. In this review, we will focus on miRNAs that may affect the hemostatic and thrombotic functions of platelets, and we will discuss the different studies that have attempted to associate miRNAs with regulatory mechanisms of ITP.
尽管越来越多的研究表明 microRNAs(miRNAs)在血小板生物学中发挥着重要作用,但它们在出血性疾病中的作用才刚刚开始被研究。事实上,多项研究表明,高度表达的血小板 miRNAs 细胞内水平的改变会引发血栓形成表型。另一方面,原发性免疫性血小板减少症(ITP)被认为是获得性出血性疾病的标志,最近与外周血单个核细胞、血浆和血小板中 miRNA 水平的改变有关。在这篇综述中,我们将重点讨论可能影响血小板止血和血栓形成功能的 miRNAs,并讨论试图将 miRNAs 与 ITP 的调节机制联系起来的不同研究。